Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The U6 small nuclear RNA (U6 snRNA) is a tightly conserved, ~100-nucleotide RNA that constitutes a catalytic core of the spliceosome and is essential for pre-mRNA splicing in all eukaryotes. The SNRPE gene encodes a component of the small nuclear ribonucleoproteins (snRNPs) but a pseudogene version is typically non-functional. The described molecule — an "RNA, U6 small nuclear variant sequence with SNRPE pseudogene sequence" — likely represents either a chimeric product arising from template switching retrotransposition or a misannotated genomic locus rather than an intentional or functional molecule. While U6 snRNA and pseudogenes (such as SNRPE pseudogene) can both be present in the genome and are sometimes mobilized in transposable element activity, this specific fusion or variant is not a recognized canonical target, nor does it have therapeutic, diagnostic, or biomarker relevance according to current scientific literature and molecular biology standards. If this refers to a unique chimeric RNA or locus described in a specific research context, its functions, disease relevance, and interaction partners are unknown, and the designation should be clarified or corrected. Canonical U6 snRNA is modified post-transcriptionally (pseudouridylation, 2'-O-methylation) and localizes primarily to the nucleolus and nuclear compartments to participate in the splicing cycle. U6 snRNA is transcribed by RNA Polymerase III and interacts with multiple proteins during spliceosome assembly and activation. SNRPE pseudogenes generally do not have protein-coding function. Key Issues & Recommendation: The “RNA, U6 small nuclear variant sequence with SNRPE pseudogene sequence” is not a standard molecular entity and should be clarified. If you are referencing a specific database entry, experimental reagent, or genomic locus, more context is needed before reliable structured information can be provided. If your goal is to examine canonical U6 snRNA or SNRPE function, consult their respective standard entries. If the goal is to describe a chimeric or retrotransposed RNA, further details on the sequence and biological context are essential.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA variant with SNRPE pseudogene sequence (RNU6V).